182 related articles for article (PubMed ID: 22186790)
1. Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines.
Bassett JD; Swift SL; VanSeggelen H; Hammill JA; McGray AJ; Evelegh C; Wan Y; Bramson JL
Mol Ther; 2012 Apr; 20(4):860-9. PubMed ID: 22186790
[TBL] [Abstract][Full Text] [Related]
2. mTOR regulates memory CD8 T-cell differentiation.
Araki K; Turner AP; Shaffer VO; Gangappa S; Keller SA; Bachmann MF; Larsen CP; Ahmed R
Nature; 2009 Jul; 460(7251):108-12. PubMed ID: 19543266
[TBL] [Abstract][Full Text] [Related]
3. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice.
Linch SN; Kasiewicz MJ; McNamara MJ; Hilgart-Martiszus IF; Farhad M; Redmond WL
Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E319-27. PubMed ID: 26729864
[TBL] [Abstract][Full Text] [Related]
4. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity.
Li Q; Rao R; Vazzana J; Goedegebuure P; Odunsi K; Gillanders W; Shrikant PA
J Immunol; 2012 Apr; 188(7):3080-7. PubMed ID: 22379028
[TBL] [Abstract][Full Text] [Related]
5. Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.
Oberst MD; Augé C; Morris C; Kentner S; Mulgrew K; McGlinchey K; Hair J; Hanabuchi S; Du Q; Damschroder M; Feng H; Eck S; Buss N; de Haan L; Pierce AJ; Park H; Sylwester A; Axthelm MK; Picker L; Morris NP; Weinberg A; Hammond SA
Mol Cancer Ther; 2018 May; 17(5):1024-1038. PubMed ID: 29545330
[TBL] [Abstract][Full Text] [Related]
6. Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus.
Finn JD; Bassett J; Millar JB; Grinshtein N; Yang TC; Parsons R; Evelegh C; Wan Y; Parks RJ; Bramson JL
J Virol; 2009 Dec; 83(23):12027-36. PubMed ID: 19759135
[TBL] [Abstract][Full Text] [Related]
7. Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection.
Salek-Ardakani S; Moutaftsi M; Sette A; Croft M
J Virol; 2011 Sep; 85(17):9051-9. PubMed ID: 21715499
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL.
Serghides L; Bukczynski J; Wen T; Wang C; Routy JP; Boulassel MR; Sekaly RP; Ostrowski M; Bernard NF; Watts TH
J Immunol; 2005 Nov; 175(10):6368-77. PubMed ID: 16272289
[TBL] [Abstract][Full Text] [Related]
9. OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen.
Murata S; Ladle BH; Kim PS; Lutz ER; Wolpoe ME; Ivie SE; Smith HM; Armstrong TD; Emens LA; Jaffee EM; Reilly RT
J Immunol; 2006 Jan; 176(2):974-83. PubMed ID: 16393983
[TBL] [Abstract][Full Text] [Related]
10. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
11. During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.
Hendriks J; Xiao Y; Rossen JW; van der Sluijs KF; Sugamura K; Ishii N; Borst J
J Immunol; 2005 Aug; 175(3):1665-76. PubMed ID: 16034107
[TBL] [Abstract][Full Text] [Related]
12. The role of mTOR in memory CD8 T-cell differentiation.
Araki K; Youngblood B; Ahmed R
Immunol Rev; 2010 May; 235(1):234-43. PubMed ID: 20536567
[TBL] [Abstract][Full Text] [Related]
13. Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8
Amani MF; Rolig AS; Redmond WL
J Immunol; 2020 Oct; 205(7):1857-1866. PubMed ID: 32848035
[TBL] [Abstract][Full Text] [Related]
14. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
15. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist.
Redmond WL; Gough MJ; Charbonneau B; Ratliff TL; Weinberg AD
J Immunol; 2007 Dec; 179(11):7244-53. PubMed ID: 18025166
[TBL] [Abstract][Full Text] [Related]
16. 4-1BB Regulates Effector CD8 T Cell Accumulation in the Lung Tissue through a TRAF1-, mTOR-, and Antigen-Dependent Mechanism to Enhance Tissue-Resident Memory T Cell Formation during Respiratory Influenza Infection.
Zhou AC; Batista NV; Watts TH
J Immunol; 2019 Apr; 202(8):2482-2492. PubMed ID: 30867239
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants.
de Souza AP; de Freitas DN; Antuntes Fernandes KE; D'Avila da Cunha M; Antunes Fernandes JL; Benetti Gassen R; Fazolo T; Pinto LA; Scotta M; Mattiello R; Pitrez PM; Bonorino C; Stein RT
Clin Exp Immunol; 2016 Feb; 183(2):248-57. PubMed ID: 26437614
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.
Bassett JD; Yang TC; Bernard D; Millar JB; Swift SL; McGray AJ; VanSeggelen H; Boudreau JE; Finn JD; Parsons R; Evelegh C; Damjanovic D; Grinshtein N; Divangahi M; Zhang L; Xing Z; Wan Y; Bramson JL
Blood; 2011 Jan; 117(4):1146-55. PubMed ID: 21088134
[TBL] [Abstract][Full Text] [Related]
19. OX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites.
Othman AS; Franke-Fayard BM; Imai T; van der Gracht ETI; Redeker A; Salman AM; Marin-Mogollon C; Ramesar J; Chevalley-Maurel S; Janse CJ; Arens R; Khan SM
Front Cell Infect Microbiol; 2018; 8():247. PubMed ID: 30073152
[TBL] [Abstract][Full Text] [Related]
20. Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.
Bassett JD; Swift SL; Bramson JL
Expert Rev Vaccines; 2011 Sep; 10(9):1307-19. PubMed ID: 21919620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
